STENTYS May Solve One of The Biggest Problems In Acute Coronary Syndrome
Gonzague Issenmann, CEO and co-founder of STENTYS, spoke with OneMedRadio and shared his insights on the industry and how the company has become a success.
11045
APPOSITION II clinical trial results
STENTYS self-apposing stent proves superior to conventional treatment of Acute Myocardial Infarction. http://www.stentys.com/22/5/documents/press-releases.html
[Company Profile] Stentys
Medical device company Stentys seeks to correct the problem of poor apposition with its self-expanding stent technology.